Higher expression of the anti-apoptotic protein BCL-2 is more common in B-cell NHL than T-cell NHL and is heterogeneously expressed among the different histological subtypes [37]. The gene discussed is BCL2; the disease is B-cell non-Hodgkin lymphoma.